Jan Turek Email and Phone Number
Jan Turek work email
- Valid
- Valid
- Valid
Jan Turek personal email
Jan Turek phone numbers
With my extensive experience in leading both small and large biotechnology and pharmaceutical companies, I focus on working with those types of companies in the US and around the world to help them be successful in maximizing the value from acquiring, developing, licensing and introducing new products or technologies, with a strong focus on rare/orphan diseases. Specifically, I help biotechnology and pharmaceutical companies with:
Technology Commercialization Group (Tcg)
View- Website:
- tcgmedtech.com
- Employees:
- 8
-
PartnerTechnology Commercialization Group (Tcg) 2012 - PresentResarch Triangle Park, North CarolinaTCG works closely with medical device, diagnostic, biopharmaceutical and biotech company CEO’s and other senior executives to develop and execute successful commercial strategies for new markets and products in the US and Europe.We have experience working across a wide variety of types and sizes of companies, products and markets. Everyone on our team is a seasoned professional with many years of “hands-on” experience, all former senior executives of successful healthcare corporations each with, on average, 25 years experience. All have clear track records of creating value with new businesses and in bringing new products to market.
-
Interim Chief Of Us Commercial OperationsPharmaessentia Corporation Jul 2016 - Jun 2017United StatesPharmaEssentia Corporation is a global, fully integrated biopharmaceutical company publicly traded and based in Taiwan, with a market value in excess of $1.0B USD. Its flagship product, ropeginterferon alfa-2b, is a new generation PEG-interferon designed to be the purest form of interferon alpha on the market. Ropeginterferon alpha-2b is currently being explored as a potentially improved interferon therapy with less frequent dosing and a better side effect profile for several rare hematological diseases such as polycythemia vera (PV) and essential thrombocythemia (ET), each disease effecting less than 150,000 patients in the USA.PharmaEssentia plans to market and sell ropeginterferon alfa-2b around the world, including in the US.Reporting to the World-Wide CEO of Pharmaessentia, the Chief of US Commercial Operations provides the leadership, management and vision necessary to effectively establish and grow the company’s business in the US. • Develop and implement the Pharmaessentia US business strategy and financial plans, focusing on the launch of ropeginterferon alfa-2b in PV• Lead the US commercial operations to establish Pharmaessentia as a leader in myloproliferative neoplasms (MPNs), such as PV and ET• Motivate and lead a high performance management team; attract, recruit and retain required members of the team not currently in place• Lead the activities of the US commercial organization, particularly focusing on pre-launch programs, launch preparations and implementation for ropeginterferon alfa-2b• Foster relationships with key MPN stakeholders• Lead the establishment and implementation of key strategies and plans necessary for the US launch of ropeginterferon alfa-2b
-
CeoBiolex Therapeutics 2001 - 2012 -
Worldwide Svp And General ManagerBayer Biologics 1996 - 2001
-
Svp Of Worldwide Sales And MarketingBayer Biologics 1993 - 1996
-
Head Of Worldwide Strategic Marketing - Cv ProductsBayer Pharmaceuticals 1990 - 1993 -
Marketing Director, PharmaceuticalsBayer Canada (Formerly Miles Canada) 1987 - 1990
-
Senior Marketing PositionsMead Johnson Canada (Division Of Bristol Myers) 1980 - 1987
-
Hospital And Physician Sales RepresentativeSandoz Canada 1976 - 1979
Jan Turek Skills
Jan Turek Education Details
-
Biochemistry
Frequently Asked Questions about Jan Turek
What company does Jan Turek work for?
Jan Turek works for Technology Commercialization Group (Tcg)
What is Jan Turek's role at the current company?
Jan Turek's current role is Senior Pharmaceutical/Biotech Executive Specializing in Interim Management and Strategic Advisory Services.
What is Jan Turek's email address?
Jan Turek's email address is jt****@****lex.com
What is Jan Turek's direct phone number?
Jan Turek's direct phone number is +191994*****
What schools did Jan Turek attend?
Jan Turek attended Mcgill University.
What skills is Jan Turek known for?
Jan Turek has skills like Biotechnology, Biopharmaceuticals, Mergers And Acquisitions, Business Development, Immunology, Infectious Diseases, Venture Financing, Cardiovascular Disease, Product Licensing, Coagulation, Antivirals, Cns Diseases.
Who are Jan Turek's colleagues?
Jan Turek's colleagues are Travis Lindsay, Reinhard Merz, Jim Woodward.
Not the Jan Turek you were looking for?
-
Jan Turek
Supply Chain Director At Pivovary Staropramen (A Molson Coors Beverage Company)Prague, Czechia1cchellenic.com -
1cemsmail.org
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial